BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

OXiGENE, Inc. 

230 Third Avenue

Waltham  Massachusetts  02451  U.S.A.
Phone: 781-547-5900 Fax: 781-547-6800


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
OXiGENE (OXGN) Announces Second Quarter 2014 Earnings Conference Call And Webcast 7/24/2014 9:10:19 AM
OXiGENE (OXGN) Names Experienced Biotech Executive, David J. Chaplin, Ph.D., As President And Chief Executive Officer 5/16/2014 7:14:59 AM
OXiGENE (OXGN) Reports First Quarter 2014 Financial Results 5/7/2014 9:08:45 AM
OXiGENE (OXGN) Announces First Quarter 2014 Earnings Conference Call And Webcast 4/23/2014 8:56:56 AM
OXiGENE (OXGN) Announces Results Of Promising Preclinical Studies At 2014 American Association for Cancer Research Conference 4/7/2014 8:58:22 AM
OXiGENE (OXGN) Announces Presentation Of Three Preclinical Abstracts At 2014 American Association for Cancer Research Conference 3/27/2014 9:51:18 AM
OXiGENE (OXGN) Reports Full Year 2013 Financial Results 3/19/2014 9:30:36 AM
OXiGENE (OXGN) Announces Updated Time For Presentation At The ROTH Conference 3/12/2014 9:02:16 AM
Slumpy OXiGENE (OXGN) Soars On Ovarian Cancer Drug Results 3/12/2014 7:25:47 AM
OXiGENE (OXGN) Announces Presentation At The ROTH Conference On March 11, 2014 3/7/2014 9:24:32 AM
12345678910...